PATENT CLAIM ANALYSIS

Application Number: 16438135
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["544", "281000"]

Abstract:
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

Claim (Index 8):
The compound of  claim 1 , further defined as a compound of Formula (VII): wherein:\n R 0g  is H or NH 2 ; \n R 1g  is selected from the group consisting of C 1 -C 6  alkyl; \n R 2g  is selected from the group consisting of C 1 -C 6  alkyl.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.05882
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15139164', '15543826', '14904801', '14451600', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8073328406076374
- 35 USC 102 Novelty (BERT): 0.5921480338809382
- Combined Prediction Score: 0.7858143599349675
- Mean Citation Score: 405.063252
- Max Citation Score: 495.0762
- Similarity Product: 473.1855089087605

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test